%0 Journal Article %T Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer %A Matsuo, Yukinori %J Journal of Thoracic Disease %D 2018 %B 2018 %9 %! Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer %K %X Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass (SMM) and strength with a risk of adverse outcomes such as physical disability, poor quality of life, and death by the European Working Group on Sarcopenia in Older People (EWGSOP) (1). %U https://jtd.amegroups.org/article/view/25349 %P S443-S445 %@ 2077-6624